For example, in one clinical study we found that ERRγ mRNA is significantly overexpressed in surgical (i.e. pre-treatment) ER+ breast tumor specimens from women who relapsed while receiving TAM [24], but this result is either not observed or not statistically significant in several other publicly available datasets of TAM-treated, ER+ breast cancer patients. The gene discussed is ESR1; the disease is breast carcinoma.